A Philadelphia cell therapy developer has initiated its first human testing of a potential cancer treatment. Vittoria ...

Vittoria Biotherapeutics, Inc. has announced the launch of its Phase 1 clinical trial for VIPER-101, a cutting-edge ...

Trial is evaluating VIPER-101, a novel, gene edited, autologous dual-population CAR-T therapy in patients with T cell lymphomaVIPER-101 was ...

More than four years later—and after two rejections from the agency—Mesoblast has finally gained an endorsement from the U.S.

The 52-year-old says Perricone MD’s High Potency Retinol Recovery Overnight Moisturizer is ... The powerful ingredient ...

Regulatory Approval Showcases Clinical Advancement of Linea DNA™ as a Rapid and Effective Means of Producing CAR-T cell Therapies -STONY BROOK, ...

July 22, 2024 — The effectiveness of CAR T cell therapy against a variety of cancers, including solid tumors, could be boosted greatly by using CRISPR-Cas9 technology to knock out the gene for ...

Antibody-drug conjugates (ADCs) represent a promising cancer treatment modality designed to deliver highly potent cytotoxic ...

Opna Bio AG has presented promising data regarding their EP300/CBP inhibitor OPN-6602 for the treatment of multiple myeloma (MM). The inhibition of EP300/CBP causes cell cycle arrest and apoptosis in ...

You've got a lot to consider when searching for the best cell phone plan, whether it's what kind of coverage you can expect or what kind of perks come with your plan. But the main question I wind ...

In a new episode of the pharmaphorum podcast, web editor Nicole Raleigh discusses stem cell therapy, and accessibility to and affordability of such treatment, with Rafael E Carazo Salas ...

Job Title: Editorial Director, Health and Applied Sciences, Nature Portfolio (m/f/d) Location: New York or Berlin Reports to: VP of Research Journa... Job Title: Chief Editor, Nature Sensors (m/f ...